Acción 455 TIANDA PHARMACEUTICALS LIMITED
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Tianda Pharmaceuticals Limited

Acciones

455

KYG887471038

Mercado cerrado - Hong Kong S.E.
Otros sitios de cotización
 10:08:06 30/04/2024 		Varia. Cinco días. Varia. 1 de enero.
0,26 HKD 0,00 % Gráfico intradía de Tianda Pharmaceuticals Limited 0,00 % +19,27 %
26/03 Tianda Pharmaceuticals Limited informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023 CI
21/03 Tianda Pharmaceuticals Limited proporciona una orientación de ganancias consolidadas para el año en curso desde el 1 de enero de 2023 hasta el 31 de diciembre de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Tianda Pharmaceuticals Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024
Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Current Year from 1 January 2023 to 31 December 2023
Tianda Pharmaceuticals Limited Announces Executive Changes, Effective 29 August 2023
Tianda Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2023
Tianda Pharmaceuticals to Shrink H1 Loss by Over 70%
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Interim Period Ended June 30, 2023
Tianda Unit Buys Out 45% Stake in Meng Sheng Pharmaceutical
Tianda Pharmaceuticals Limited entered into an equity transfer agreement to acquire 45% stake in Yunnan Mengsheng Pharmaceutical Co., Ltd from Yunnan Linuo Biotechnology Co., Ltd. for HKD 23.5 million.
Tianda Pharmaceuticals Limited Announces Board Changes
Tianda Pharmaceuticals Limited Approves Final Dividend
Tianda Pharmaceuticals Limited Proposes Final Dividend for the Nine Months Ended 31 December 2022, Payable on or Before, 14 July 2023
Tianda Pharmaceuticals Unit to Invest HK$10 Million in Fund
Beijing Tong Ren Tang Chinese Medicine’s CEO Redesignated; New CEO Named
Tianda Pharmaceuticals Limited Announces Final Ordinary Dividend for the Nine Months Ended 31 December 2023
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022
Tianda Pharmaceuticals Warns of Higher Loss in Fiscal Nine-Month Period; Shares Tumble 9%
Tianda Pharmaceuticals Limited Provides Group Earnings Guidance for the Nine Months Period from April 1, 2022 to December 31, 2022
Tianda Pharmaceuticals to Set Up Additional Production Line to Meet Rising Medicine Demand
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción 455
  4. Noticias Tianda Pharmaceuticals Limited
  5. Otros idiomas